These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

979 related items for PubMed ID: 8983073

  • 1. Possible involvement of VEGF-FLT tyrosine kinase receptor system in normal and tumor angiogenesis.
    Shibuya M, Seetharam L, Ishii Y, Sawano A, Gotoh N, Matsushime H, Yamaguchi S.
    Princess Takamatsu Symp; 1994; 24():162-70. PubMed ID: 8983073
    [Abstract] [Full Text] [Related]

  • 2. A new communication system between hepatocytes and sinusoidal endothelial cells in liver through vascular endothelial growth factor and Flt tyrosine kinase receptor family (Flt-1 and KDR/Flk-1).
    Yamane A, Seetharam L, Yamaguchi S, Gotoh N, Takahashi T, Neufeld G, Shibuya M.
    Oncogene; 1994 Sep; 9(9):2683-90. PubMed ID: 8058332
    [Abstract] [Full Text] [Related]

  • 3. A unique signal transduction from FLT tyrosine kinase, a receptor for vascular endothelial growth factor VEGF.
    Seetharam L, Gotoh N, Maru Y, Neufeld G, Yamaguchi S, Shibuya M.
    Oncogene; 1995 Jan 05; 10(1):135-47. PubMed ID: 7824266
    [Abstract] [Full Text] [Related]

  • 4. A novel vascular endothelial growth factor encoded by Orf virus, VEGF-E, mediates angiogenesis via signalling through VEGFR-2 (KDR) but not VEGFR-1 (Flt-1) receptor tyrosine kinases.
    Meyer M, Clauss M, Lepple-Wienhues A, Waltenberger J, Augustin HG, Ziche M, Lanz C, Büttner M, Rziha HJ, Dehio C.
    EMBO J; 1999 Jan 15; 18(2):363-74. PubMed ID: 9889193
    [Abstract] [Full Text] [Related]

  • 5. Two independent mechanisms essential for tumor angiogenesis: inhibition of human melanoma xenograft growth by interfering with either the vascular endothelial growth factor receptor pathway or the Tie-2 pathway.
    Siemeister G, Schirner M, Weindel K, Reusch P, Menrad A, Marmé D, Martiny-Baron G.
    Cancer Res; 1999 Jul 01; 59(13):3185-91. PubMed ID: 10397264
    [Abstract] [Full Text] [Related]

  • 6. Complete inhibition of vascular endothelial growth factor (VEGF) activities with a bifunctional diabody directed against both VEGF kinase receptors, fms-like tyrosine kinase receptor and kinase insert domain-containing receptor.
    Lu D, Jimenez X, Zhang H, Wu Y, Bohlen P, Witte L, Zhu Z.
    Cancer Res; 2001 Oct 01; 61(19):7002-8. PubMed ID: 11585724
    [Abstract] [Full Text] [Related]

  • 7. Coordinate expression of vascular endothelial growth factor receptor-1 (flt-1) and its ligand suggests a paracrine regulation of murine vascular development.
    Breier G, Clauss M, Risau W.
    Dev Dyn; 1995 Nov 01; 204(3):228-39. PubMed ID: 8573716
    [Abstract] [Full Text] [Related]

  • 8. Role of VEGF receptor-1 (Flt-1) in mediating calcium-dependent nitric oxide release and limiting DNA synthesis in human trophoblast cells.
    Ahmed A, Dunk C, Kniss D, Wilkes M.
    Lab Invest; 1997 Jun 01; 76(6):779-91. PubMed ID: 9194854
    [Abstract] [Full Text] [Related]

  • 9. Vascular endothelial growth factor up-regulates its receptor fms-like tyrosine kinase 1 (FLT-1) and a soluble variant of FLT-1 in human vascular endothelial cells.
    Barleon B, Siemeister G, Martiny-Baron G, Weindel K, Herzog C, Marmé D.
    Cancer Res; 1997 Dec 01; 57(23):5421-5. PubMed ID: 9393770
    [Abstract] [Full Text] [Related]

  • 10. Vascular endothelial growth factor-induced migration of vascular smooth muscle cells in vitro.
    Grosskreutz CL, Anand-Apte B, Dupláa C, Quinn TP, Terman BI, Zetter B, D'Amore PA.
    Microvasc Res; 1999 Sep 01; 58(2):128-36. PubMed ID: 10458928
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. The short form of the alternatively spliced flt-4 but not its ligand vascular endothelial growth factor C is related to lymph node metastasis in human breast cancers.
    Gunningham SP, Currie MJ, Han C, Robinson BA, Scott PA, Harris AL, Fox SB.
    Clin Cancer Res; 2000 Nov 01; 6(11):4278-86. PubMed ID: 11106244
    [Abstract] [Full Text] [Related]

  • 14. The 230 kDa mature form of KDR/Flk-1 (VEGF receptor-2) activates the PLC-gamma pathway and partially induces mitotic signals in NIH3T3 fibroblasts.
    Takahashi T, Shibuya M.
    Oncogene; 1997 May 01; 14(17):2079-89. PubMed ID: 9160888
    [Abstract] [Full Text] [Related]

  • 15. PTK787/ZK 222584, a novel and potent inhibitor of vascular endothelial growth factor receptor tyrosine kinases, impairs vascular endothelial growth factor-induced responses and tumor growth after oral administration.
    Wood JM, Bold G, Buchdunger E, Cozens R, Ferrari S, Frei J, Hofmann F, Mestan J, Mett H, O'Reilly T, Persohn E, Rösel J, Schnell C, Stover D, Theuer A, Towbin H, Wenger F, Woods-Cook K, Menrad A, Siemeister G, Schirner M, Thierauch KH, Schneider MR, Drevs J, Martiny-Baron G, Totzke F.
    Cancer Res; 2000 Apr 15; 60(8):2178-89. PubMed ID: 10786682
    [Abstract] [Full Text] [Related]

  • 16. Differential regulation of vascular endothelial growth factor and its receptor fms-like-tyrosine kinase is mediated by nitric oxide in rat renal mesangial cells.
    Frank S, Stallmeyer B, Kämpfer H, Schaffner C, Pfeilschifter J.
    Biochem J; 1999 Mar 01; 338 ( Pt 2)(Pt 2):367-74. PubMed ID: 10024512
    [Abstract] [Full Text] [Related]

  • 17. Suppression of tumor angiogenesis and growth by gene transfer of a soluble form of vascular endothelial growth factor receptor into a remote organ.
    Takayama K, Ueno H, Nakanishi Y, Sakamoto T, Inoue K, Shimizu K, Oohashi H, Hara N.
    Cancer Res; 2000 Apr 15; 60(8):2169-77. PubMed ID: 10786681
    [Abstract] [Full Text] [Related]

  • 18. Developmental expression of vascular endothelial growth factor (VEGF) receptors and VEGF binding in ovine placenta and fetal membranes.
    Bogic LV, Brace RA, Cheung CY.
    Placenta; 2001 Apr 15; 22(4):265-75. PubMed ID: 11286562
    [Abstract] [Full Text] [Related]

  • 19. The second immunoglobulin-like domain of the VEGF tyrosine kinase receptor Flt-1 determines ligand binding and may initiate a signal transduction cascade.
    Davis-Smyth T, Chen H, Park J, Presta LG, Ferrara N.
    EMBO J; 1996 Sep 16; 15(18):4919-27. PubMed ID: 8890165
    [Abstract] [Full Text] [Related]

  • 20. Treatment for malignant pleural effusion of human lung adenocarcinoma by inhibition of vascular endothelial growth factor receptor tyrosine kinase phosphorylation.
    Yano S, Herbst RS, Shinohara H, Knighton B, Bucana CD, Killion JJ, Wood J, Fidler IJ.
    Clin Cancer Res; 2000 Mar 16; 6(3):957-65. PubMed ID: 10741721
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 49.